Long-term Response to First-line Pazopanib Therapy in mRCC Patients: A Multicenter Italian Experience.
Sbrana A, Biasco E, Paolieri F, Palesandro E, Caserta C, Iacovelli R, Detti B, Santini D, Mosca A, Morelli F, Fornarini G, De Giorgi U, Masini C, Galli L.
Sbrana A, et al.
Anticancer Res. 2018 Aug;38(8):4913-4918. doi: 10.21873/anticanres.12807.
Anticancer Res. 2018.
PMID: 30061269